Cited 6 times in
Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이용찬 | - |
dc.date.accessioned | 2016-02-04T11:48:14Z | - |
dc.date.available | 2016-02-04T11:48:14Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0163-2116 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/141238 | - |
dc.description.abstract | BACKGROUND: There has been no study on the efficacy of lafutidine for patients with reflux esophagitis in Korea. AIM: To evaluate the efficacy of a new-generation histamine-2 receptor antagonist, lafutidine, in comparison with famotidine in patients with reflux esophagitis. METHODS: This was a randomized, double-blind, non-inferiority trial enrolling patients with erosive esophagitis. The efficacy and safety of 20 mg lafutidine (treatment group) were compared with those of 40 mg famotidine (control group) and 20 mg omeprazole (reference group). The primary endpoint was the complete healing rates of reflux esophagitis on endoscopy after 8 weeks of treatment. The non-inferiority margin was assumed to be -15 %. RESULTS: The healing rates of reflux esophagitis on endoscopy after 8 weeks of treatment were 70.14 % (101/144) in the lafutidine, 63.45 % (92/145) in the famotidine, and 85.71 % (126/147) in the omeprazole group. The difference in healing rates between the lafutidine and famotidine groups was 6.69 % (95 % confidence interval = [-4.14 to 17.52]). In addition, lafutidine was superior to famotidine in clinical improvement (53.73 % vs. 39.55 %, P = 0.0200). CONCLUSIONS: Lafutidine was non-inferior to famotidine in healing of reflux esophagitis. Lafutidine, however, was superior to famotidine in terms of symptom relief of reflux esophagitis. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 1724~1732 | - |
dc.relation.isPartOf | DIGESTIVE DISEASES AND SCIENCES | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Acetamides/therapeutic use* | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Anti-Ulcer Agents/therapeutic use* | - |
dc.subject.MESH | Double-Blind Method | - |
dc.subject.MESH | Esophagitis, Peptic/drug therapy* | - |
dc.subject.MESH | Esophagoscopy | - |
dc.subject.MESH | Famotidine/therapeutic use* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Medication Adherence | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Omeprazole/therapeutic use | - |
dc.subject.MESH | Piperidines/therapeutic use* | - |
dc.subject.MESH | Pyridines/therapeutic use* | - |
dc.subject.MESH | Republic of Korea | - |
dc.subject.MESH | Severity of Illness Index | - |
dc.subject.MESH | Treatment Outcome | - |
dc.title | Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Eun Hye Kim | - |
dc.contributor.googleauthor | Yong Chan Lee | - |
dc.contributor.googleauthor | Young Woon Chang | - |
dc.contributor.googleauthor | Jong-Jae Park | - |
dc.contributor.googleauthor | Hoon Jai Chun | - |
dc.contributor.googleauthor | Hwoon-Yong Jung | - |
dc.contributor.googleauthor | Hyun-Soo Kim | - |
dc.contributor.googleauthor | Hyun Yong Jeong | - |
dc.contributor.googleauthor | Sang-Young Seol | - |
dc.contributor.googleauthor | Sok Won Han | - |
dc.contributor.googleauthor | Myung-Gyu Choi | - |
dc.contributor.googleauthor | Soo-Heon Park | - |
dc.contributor.googleauthor | Ok-Jae Lee | - |
dc.contributor.googleauthor | Jin Tae Jung | - |
dc.contributor.googleauthor | Dong Ho Lee | - |
dc.contributor.googleauthor | Hyun Chae Jung | - |
dc.contributor.googleauthor | Soo Teik Lee | - |
dc.contributor.googleauthor | Jae Gyu Kim | - |
dc.contributor.googleauthor | Sei Jin Youn | - |
dc.contributor.googleauthor | Hak Yang Kim | - |
dc.contributor.googleauthor | Sang Woo Lee | - |
dc.identifier.doi | 10.1007/s10620-014-3489-4 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02988 | - |
dc.relation.journalcode | J00737 | - |
dc.identifier.eissn | 1573-2568 | - |
dc.identifier.pmid | 25532503 | - |
dc.identifier.url | http://link.springer.com/article/10.1007%2Fs10620-014-3489-4 | - |
dc.subject.keyword | Lafutidine | - |
dc.subject.keyword | Famotidine | - |
dc.subject.keyword | Omeprazole | - |
dc.subject.keyword | Reflux esophagitis | - |
dc.contributor.alternativeName | Lee, Yong Chan | - |
dc.contributor.affiliatedAuthor | Lee, Yong Chan | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 60 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1724 | - |
dc.citation.endPage | 1732 | - |
dc.identifier.bibliographicCitation | DIGESTIVE DISEASES AND SCIENCES, Vol.60(6) : 1724-1732, 2015 | - |
dc.identifier.rimsid | 31429 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.